Japan Lifeline Co., Ltd.

Equities

7575

JP3754500001

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange 02:00:00 2024-04-16 am EDT 5-day change 1st Jan Change
1,157 JPY -1.53% Intraday chart for Japan Lifeline Co., Ltd. -0.17% -8.39%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Japan Lifeline Completes Cancellation of 7.16 Million Shares MT
Tranche Update on Japan Lifeline Co., Ltd.'s Equity Buyback Plan announced on May 10, 2023. CI
Japan Lifeline Co., Ltd.'s Equity Buyback announced on May 10, 2023, has closed with 3,000,000 shares, representing 3.9% for ¥3,319.77 million. CI
Japan Lifeline Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2024 CI
Japan Lifeline Co., Ltd. Announces the Appointment of Nobuo Takahashi as Operating Officer, Associate Executive Manager of CVG Business Unit CI
Japanese Shares Return to Green on Upbeat Economic Data MT
Japan Lifeline Buys Back Shares Worth Over 217 Million Yen MT
Tranche Update on Japan Lifeline Co., Ltd.'s Equity Buyback Plan announced on May 10, 2023. CI
Japan Lifeline Buys Back 244,300 Shares for 272.88 Million Yen MT
Japan Lifeline Co., Ltd. Announces Management Changes CI
Japan Lifeline Raises Forecasts for Fiscal 2024 After Better than Expected First Half MT
Japan Lifeline Co., Ltd. Revises Year End Dividend Guidance for the Fiscal Year 2024 CI
Japan Lifeline Co., Ltd. Revises Consolidated and Non-Consolidated Earnings Guidance for the Fiscal Year Ending 31, 2024 CI
Japan Lifeline Co., Ltd. Enters into Exclusive Distribution Agreement with Meril Life Sciences Pvt. Ltd CI
Tranche Update on Japan Lifeline Co., Ltd.'s Equity Buyback Plan announced on May 10, 2023. CI
Japan Lifeline Completes Disposal of 69,000 Shares for 68.31 Million Yen MT
Japan Lifeline Launches Open Stent Graft Product MT
Japan Lifeline Co., Ltd. Announces That It Will Start Selling A New Lineup of Its Proprietary Open Stent Graft Product Frozenix Partial ET from August 2023 CI
Japanese Shares Gain on Upbeat Performance of Manufacturing, Transport, Railway and Bus Sectors MT
Japan Lifeline to be Included in JPX-Nikkei Mid and Small Cap Index MT
Japan Lifeline Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2023 and Year Ending March 31, 2024 CI
Japan Lifeline Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2024 CI
Tranche Update on Japan Lifeline Co., Ltd.'s Equity Buyback Plan announced on May 10, 2023. CI
Japan Lifeline Co., Ltd. Enters into Exclusive Distribution Agreement with Haemonetics Japan GK CI
Japan Lifeline Repurchases Shares Worth 315.5 Million Yen in May MT
Chart Japan Lifeline Co., Ltd.
More charts
Japan Lifeline Co., Ltd. is a Japan-based company mainly engaged in the import, manufacture and sale of cardiac circulators and other medical devices. The Company is mainly engaged in the production of rhythm devices, electrophysiological (EP) and ablations, surgical products and intervention products. The rhythm devices include cardiac pacemakers, implantable cardioverter defibrillator (ICD), cardiac resynchronization therapy defibrillator (CRT-D) and other rhythm devices. The EP and ablations include EP catheters for cardiac arrhythmia examination, ablation catheters for arrhythmia treatment and other EP and ablations. The surgical products include prosthetic heart valves and annuloplasty rings for heart disease surgical treatment, vascular grafts, open stent grafts and stent grafts for aortic disease treatment, as well as other surgical products. The intervention products include balloon catheters, guide wires, penetration catheters and other intervention products.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
1,175 JPY
Average target price
1,450 JPY
Spread / Average Target
+23.40%
Consensus
  1. Stock Market
  2. Equities
  3. 7575 Stock
  4. News Japan Lifeline Co., Ltd.
  5. Japan Lifeline : Boston Scientific to Commence Monitoring of Patients with Japan Lifeline Defibrillator